Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT04069143 | A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327 | PHASE1 | COMPLETED | 14 | — | — | Oct 1, 2019 | Jul 12, 2022 | Mar 7, 2023 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| Part 1 | EXPERIMENTAL | - |
| Part 2 | EXPERIMENTAL | - |
| Part 3 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| 18F-BMS-986327 | DIAGNOSTIC_TEST | Imaging Agent |
Inclusion Criteria: All Participants: · Body mass index of 18.0 to 34.0 kg/m\^2, inclusive, and body weight ≥ 50 kg Healthy Participants: * Male and female healthy volunteers ages 18 or age or older * No clinically significant deviation from normal in medical history, physical examination, elect...